XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows From Operating Activities    
Net income (loss) $ 1,655,021 $ (1,209,390)
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 112,017 381,119
Deferred tax benefit 31,704 (188,117)
Stock compensation expense 595,677 449,889
Termination cost on Academic E-commerce platform (Note 6) 0 800,000
Changes in bad debt allowance 321,970 324,684
Changes in operating assets and liabilities:    
Accounts receivable (941,413) 16,614,186
Advance to suppliers (2,181,584) (7,444,924)
Inventories 153,740 489,152
Other current assets 35,452 112,991
Accounts payable (295,656) (1,458,241)
Advance from customers 23,395 21,529
Accrued liabilities and other payables (113,806) (151,606)
Taxes payable 215,554 18,097
Net Cash (Used in) Provided by Operating Activities (387,929) 8,759,369
Cash Flows From Investing Activities    
Assignment fee received 0 1,250,000
Purchase of property and equipment (11,499) (2,132)
Advances to unrelated parties 0 (8,835,000)
Net Cash Used in Investing Activities (11,499) (7,587,132)
Cash Flows From Financing Activities    
Proceeds from line of credit and bank loan 15,923,479 15,469,342
Repayment to line of credit and bank loan (20,125,597) (18,939,032)
Net Cash Used in Financing Activities (4,202,118) (3,469,690)
Net decrease in cash and cash equivalents (4,601,546) (2,297,453)
Cash and cash equivalents, beginning of period 5,722,716 2,587,743
Cash and cash equivalents, end of period 1,121,170 290,290
Analysis of cash and cash equivalents    
Included in cash and cash equivalents per consolidated balance sheets 1,121,170 290,290
Cash and cash equivalents, end of period 1,121,170 290,290
Cash paid during the period for:    
Income tax payments 0 0
Interest paid $ 31,582 $ 54,406